State Board of Administration of Florida Retirement System
GTBP icon

State Board of Administration of Florida Retirement System’s GT Biopharma GTBP Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-607
Closed -$52K – 2356
2022
Q1 		$52K Hold
607
– – ﹤0.01% 2328
2021
Q4 		$56K Hold
607
– – ﹤0.01% 2370
2021
Q3 		$123K Buy
+607
New +$183K ﹤0.01% 2335

Other funds holding GTBP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Board of Administration of Florida Retirement System's GTBP Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of GT Biopharma (GTBP) in Q2 2022, closing a stake of 607 shares — an estimated $52K sold.

State Board of Administration of Florida Retirement System first reported a position in GTBP in Q3 2021 and held it in 3 quarters. The position peaked at $123K in Q3 2021. 47 funds tracked by Wall St. Rank hold GTBP as of Q2 2022.

  • State Board of Administration of Florida Retirement System reported no remaining GT Biopharma position as of Q2 2022 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 607 GT Biopharma shares in Q2 2022, an estimated $52K.
  • State Board of Administration of Florida Retirement System first reported a position in GT Biopharma in Q3 2021 and held it in 3 quarters.
  • State Board of Administration of Florida Retirement System's GT Biopharma position peaked at $123K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.